Allurion files PMA submission of Elipse Gastric Balloon with FDAAllurion Technologies is one step closer to having its Elipse gastric balloon enter the US market, after company announced the PMA...
SOUL trial: Oral semaglutide demonstrates a 14% reduction in risk of major adverse CV events2 days ago